Variant report
Variant | esv3382422 |
---|---|
Chromosome Location | chr4:18905732-18933315 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34919509 | chr4:18909008-18909009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533092199 | chr4:18909015-18909016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551371560 | chr4:18909029-18909030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200694740 | chr4:18909030-18909031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531535610 | chr4:18909031-18909032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34295055 | chr4:18909184-18909185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs546003670 | chr4:18913808-18913809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564300882 | chr4:18913818-18913819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140058441 | chr4:18913831-18913832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534896572 | chr4:18913838-18913839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370626706 | chr4:18913845-18913846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547079839 | chr4:18913872-18913873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562218962 | chr4:18913909-18913910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529224637 | chr4:18913912-18913913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547405797 | chr4:18913934-18913935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559582134 | chr4:18913956-18913957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150276637 | chr4:18913957-18913958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77760524 | chr4:18914038-18914039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570195936 | chr4:18914068-18914069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537663393 | chr4:18914099-18914100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181416313 | chr4:18914109-18914110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568171512 | chr4:18914117-18914118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185699412 | chr4:18914121-18914122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370113727 | chr4:18914176-18914177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553838184 | chr4:18914268-18914269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189866570 | chr4:18914314-18914315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112079864 | chr4:18914347-18914348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558921615 | chr4:18914351-18914352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539790697 | chr4:18914356-18914357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78607119 | chr4:18914444-18914445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576115940 | chr4:18914463-18914464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368014232 | chr4:18914467-18914468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182129544 | chr4:18914481-18914482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs541151201 | chr4:18914507-18914508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555549809 | chr4:18914525-18914526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141786627 | chr4:18914533-18914534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373965094 | chr4:18914538-18914539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116984416 | chr4:18914598-18914599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368112643 | chr4:18914607-18914608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559370160 | chr4:18914612-18914613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533438809 | chr4:18914647-18914648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370895137 | chr4:18914655-18914656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545258877 | chr4:18914701-18914702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564012292 | chr4:18914743-18914744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147085359 | chr4:18914786-18914787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71653805 | chr4:18914828-18914829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13129810 | chr4:18914830-18914831 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs568048487 | chr4:18914846-18914847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115592027 | chr4:18914847-18914848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530042891 | chr4:18914873-18914874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:18909000-18909200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr4:18913800-18915200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:18914800-18916800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr4:18914800-18916800 | Enhancers | NHEK | skin |
5 | chr4:18915000-18916600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr4:18915200-18916000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr4:18915200-18916800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr4:18915200-18916800 | Enhancers | HMEC | breast |
9 | chr4:18925200-18926800 | Enhancers | Fetal Heart | heart |
10 | chr4:18925400-18925800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr4:18932000-18932400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr4:18932400-18937400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |